| Name | Title | Contact Details |
|---|
Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve outcomes for patients with cancer. The Company is working to establish a new treatment paradigm in which rationally-designed, fully-integrated combination products replace combination regimens of individual agents. Celator`s proprietary technology platform, CombiPlex®, identifies the most effective synergistic ratio of the component drugs, optimizes the pharmacology of the drug combination prior to human clinical trials, allows simultaneous administration of the components as a single product and maintains the synergistic ratio of the components after administration thereby exposing tumor cells to the right amounts of drug for the right length of time.
Inspiration, imagination, and innovation. We share this passion for finding new approaches to protecting vision. United by great science, deep clinical insight, and a singular focus on your ophthalmic needs, we see the possibilities ahead and invite you to join us in creating the future of eye care. Aerie Pharmaceuticals discovers, develops, and commercializes first-in-class therapies for the treatment of patients with glaucoma, retinal diseases and other diseases of the eye. See the future of eye care with Aerie.
Audible Difference is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
LifeScript is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
ACI Medical is a San Marcos, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.